PHILADELPHIA, PA — Researchers at Temple University Lewis Katz School of Medicine say a little-known compound could mark a ...

When it comes to pharmacology, the big story these days is the development of the “glucagon-like peptide-1 (GLP-1) mimics,” ...

Could this mark a shift in how we think about cancer therapy? At least in the laboratory, evidence suggests it may be . An international research team has succeeded in deciphering a key mechanism that ...